FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

15 results

dapagliflozin and metformin hydrochloride
(Dapagliflozin And Metformin Hydrochloride)
Medication Details
Lupin Pharmaceuticals, Inc.
Usage: Dapagliflozin and metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. They also reduce the risk of kidney and cardiovascular complications in specific patient populations with chronic kidney disease or heart failure.
Medication Details
Drug Interactions
farxiga
(DAPAGLIFLOZIN)
Medication Details
AstraZeneca Pharmaceuticals LP
Usage: FARXIGA (dapagliflozin) is indicated for reducing risks associated with chronic kidney disease, heart failure, and for improving glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus, alongside diet and exercise. It is not recommended for type 1 diabetes or specific kidney conditions.
Medication Details
Drug Interactions
ferrlecit
(sodium ferric gluconate complex)
Medication Details
sanofi-aventis U.S. LLC
Usage: Ferrlecit is indicated for treating iron deficiency anemia in adults and pediatric patients aged 6 and older with chronic kidney disease undergoing hemodialysis and receiving supplemental epoetin therapy.
Medication Details
Drug Interactions
furoscix
(furosemide injection 80 mg/ 10 mL)
Medication Details
scPharmaceuticals Inc.
Usage: FUROSCIX is indicated for treating edema in adults with chronic heart failure or chronic kidney disease (CKD), including those with nephrotic syndrome.
Medication Details
Drug Interactions
injectafer
(Ferric Carboxymaltose Injection)
Medication Details
American Regent, Inc.
Usage: Injectafer is indicated for treating iron deficiency anemia in patients aged 1 year and older with oral iron intolerance or unsatisfactory response, and in non-dialysis dependent chronic kidney disease. It also treats iron deficiency in adults with heart failure (NYHA class II/III) to improve exercise capacity.
Medication Details
Drug Interactions
kerendia
(finerenone)
Medication Details
Bayer Healthcare Pharmaceuticals Inc.
Usage: Kerendia is indicated for reducing the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.
Medication Details
Drug Interactions
ozempic
(semaglutide)
Medication Details
Novo Nordisk
Usage: OZEMPIC is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes. It also reduces the risk of major adverse cardiovascular events and helps in preventing kidney disease progression in patients with type 2 diabetes and chronic kidney disease.
Medication Details
Drug Interactions
renvela
(SEVELAMER CARBONATE)
Medication Details
Genzyme Corporation
Usage: Renvela (sevelamer carbonate) is indicated for controlling serum phosphorus levels in adults and children aged 6 and older with chronic kidney disease (CKD) who are on dialysis.
Medication Details
Drug Interactions
sevelamer carbonate
(SEVELAMER CARBONATE)
Medication Details
Shandong Xinhua Pharmaceutical Co., Ltd.
Usage: Sevelamer carbonate tablets are indicated for controlling serum phosphorus levels in adults and children aged 6 years and older with chronic kidney disease (CKD) who are undergoing dialysis.
Medication Details
Drug Interactions
sevelamer carbonate
(Sevelamer Carbonate)
Medication Details
Winthrop U.S, a business of sanofi-aventis U.S. LLC
Usage: Sevelamer carbonate is indicated for controlling serum phosphorus levels in adults and children aged 6 and older with chronic kidney disease (CKD) undergoing dialysis.
Medication Details
Drug Interactions

Medications for Chronic Kidney Diseases

dapagliflozin and metformin hydrochloride

farxiga

ferrlecit

furoscix

injectafer

kerendia

ozempic

renvela

sevelamer carbonate

sevelamer carbonate